Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Shire submits IND application to FDA for gene therapy candidate SHP654 for treatment of hemophilia A

cphi-onlineJuly 13, 2017

Tag: Shire , Hemophilia A

PharmaSources Customer Service